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Abstract
Background: One of the causes of maternal and fetal mortality and morbidity is
pregnancy-induced hypertension, themost common form of which is preeclampsia that
causes many complications for mother and fetus.
Objective: The aim of this systematic review and meta-analysis was to determine the
relationship between body mass index (BMI) and preeclampsia in Iran.
Materials and Methods: Using valid keywords in the SID database, PubMed, Scopus,
data obtained from all the articles, which were reviewed in Iran between 2000 and
2016, were combined using the meta-analysis method (random-effects model) and
analyzed using STATA version 11.1.
Results:A total number of 5,946 samples were enrolled in 16 studies with themean BMI
values of 25.13, 27.42, and 26.33 kg /m2 in the healthy, mild, and severe preeclamptic
groups, respectively.
Conclusion: The results of this study revealed that there is a significant relationship
between BMI and the risk of preeclampsia, so it can be said that BMI may be one of
the ways to diagnose preeclampsia.
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1. Introduction
Preeclampsia is a pregnancy-related disease
that increases maternal and perinatal mortality and
morbidity (1, 2). The possible causes of preeclamp-
sia include abnormal vascular thromboembolic
invasion, lack of maternal-fetal immune tolerance
and maternal maladaptation with cardiovascular
and inflammatory changes during pregnancy and
genetics (3). Preeclampsia affects 5–8% of all
pregnancies (4) and causes many complications
for mother and fetus in such a way that 50,000
women worldwide die from preeclampsia and its
complications annually (5). Researchers believe
that preeclampsia is a multifactorial disease and
propose several risk factors for it, including a
history of preeclampsia, low and highmaternal age,
diabetes, chronic hypertension, null parity, birth
intervals, history of abortion, high body mass index
(BMI) value, twin pregnancy, fetal sex, migraine,
and maternal RH (6-10). A major part of the com-
plications and some of the risk factors proposed
for this disorder can be identified and prevented.
Although the termination of pregnancy is consid-
ered as a definitive treatment of preeclampsia,
careful prenatal care and appropriate treatment
can improve the condition, and the outcome can
be satisfactory for the mother and fetus in many
cases (11). Some studies have referred to obesity
as a risk factor for preeclampsia and showed
that the relationship between maternal weight
and preeclampsia is a progressive risk and varies
from 4.3% in women with a BMI < 19.8 Kg/m2,
up to 13.3% for women with a BMI ≥ 35 kg/m2
(12).
Since the objectives of meta-analysis include
regular and systematic review of the evidence,
the quantitative summing up of the results of
each study, combining the results of various stud-
ies and providing a general interpretation of the
results (13), the aim of the present study was to
investigate the relationship between the mater-
nal BMI and preeclampsia using the by meta-
analysis technique, performing more studies in
this area, and reducing neonatal morbidity and
mortality.
2. Materials and Methods
The present study was carried out using the
meta-analysis technique and random-effects mod-
els. It was conducted in several steps to accu-
rately determine the problem under study and
collecting, analyzing, and interpreting the findings
and using preferred reporting items for systematic
reviews and meta-analyses (PRISMA). The study
began after using the aforementioned protocol
as a research criterion as well as identifying the
members of the meta-analysis group (including
the group’s supervisor and the final reviewer, the
group’s advisor, reviewer, and researcher; data
extractor and collector; and article explorer). To
review the studies, SID, Scopus, and PubMed
databases were first systematically searched using
valid Persian keywords (preeclampsia, BMI, preg-
nancy) and valid English keywords (preeclampsia,
BMI, and pregnancy) in order to identify and evalu-
ate the studies on the prevalence of preeclampsia
in pregnant women in Iran. The studies were later
classified as case-controls.
2.1. Selection of studies and data
extraction
All articles related to preeclampsia were col-
lected and a list of articles’ abstract was later
prepared after the completion of the search. Then
all articles, in which the BMI value was specified,
were included in the first list.
Then, quality assessment was done by the
Newcastle-Ottawa Scale. The adjusted Ottawa
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checklist was used to evaluate the quality of the
studies. In this case, three subsets of the groups
(four questions), group comparability (one ques-
tion), and exposure or outcome (two questions) are
examined (14), this tool is usually used for Validity
assessment and is a reliable instrument with a long
history of reliability (15).
Studies with a score of 3 or more were con-
sidered qualitative and entered into the anal-
ysis. Other studies that addressed preeclamp-
sia, causes of preeclampsia, ways to cope with
preeclampsia, and risk factors for preeclampsia
in pregnant women were excluded from the list.
A necessary information checklist containing the
researcher’s name, article’s title, year of conduct-
ing the research, research setting, code of the
research setting, age group, sample size, BMI,
etc., were prepared for all studies that underwent
the initial evaluation in order to undergo the final
evaluation. Finally, the final checklist was reviewed
and the relevant articles were entered into the
meta-analysis. According to these steps, 101 arti-
cles were found using the keywords in the first
search. After the analysis phase, 16 appropriate
articles entered the meta-analysis phase (Figure 1,
Table I).








































16 2007 200 Case-control 26.88 24 23.17–24.73 26 25.72–26.28 26 24.86–27.14
17 2012 498 Case-control 29.01 25.91 25.27–26.55 28.99 27.63–30.35 26.29 25.31–27.27
18 2007 400 Case-control 23.19 26.24 25.97–26.51 – – 29.93 28.21–31.65
19 2012 112 Case-control 24.94 23.60 22.68–24.52 – – 22.39 20.43–24.35
20 2010 675 Case-control 32.85 21.05 – – – 21.15 –
21 2006 636 Case-control 27 – – – 23 –
22 2010 610 Case-control 22.85 – – – 20 –
23 2013 90 Case-control 27.3 25.30 24.57–26.03 – – 25.90 25.02–26.78
24 2009 187 Case-control 25.81 23.25 23.01–23.49 – – 23.47 23.19–23.75
25 2008 64 Case-control 26.37 29.14 28.96–29.32 – – 30.35 30.14–30.56
26 2010 60 Case-control 31.67 21.95 21.77–22.13 – – 23.65 23.38–23.92
27 2001 674 Case-control 24.4 24.20 23.61–24.79 – – 24 23.61–24.39
28 2010 60 Case-control 31.51 26.74 26.59–26.89 – – 27.61 27.44–27.78
29 2006 80 Case-control 23.7 12.41 – – – 12.61 –
30 2010 1200 Case-control 28.11 25.45 – – – 28.56 –
BMI: Body mass index
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101 articles entered the study 
through preliminary search 
101 articles were 
systematically reviewed 
27 low-quality articles were 
excluded 
16 high-quality papers 
entered the process  
58 articles were excluded 
due to inappropriate subject 
43 articles entered the 
next stage 
Figure 1. Flowchart of the stages of the systematic review and meta-analysis.
2.2. Inclusion and exclusion criteria
Inclusion criteria included access to the full
text of the article, English or Persian, articles
aimed at examining the relationship between the
components studied. Exclusion Criteria included
unrelated articles, the inaccessibility of the full text
of the article, and the incomplete abstract of the
article. All analyzes were performed in this study
using STATA according to the critical evaluation
criteria and the eligible articles were included in the
study.
2.3. Statistical analysis
Considering that the main index studied in this
review study was BMI, its variance was calculated
by the binomial distribution, and the odd ratio with
a 95% confidence interval (CI) was calculated. The
weighted average was used to combine the rates
obtained from different studies. Each study was
weighted inversely in proportion to its variance.
The heterogeneity was evaluated using Q test and
I2 at the given significance level (α < 10%). Data
analysis was performed using the meta-analysis
technique (random-effects model) in cases of any
heterogeneity. Data analysis was carried out using
R and STATA Version 11.2.
3. Results
In the present study, a total of 16 articles
which were published between 2000 and 2016
were reviewed and the total sample size was
5,946 women. The mean BMI was 25.13 (95%
CI: 23.52-2.74) (Figure 2), 27.42 kg (95% CI:
24.4-30.34), (Figure 3), and 26.33 kg/m2 (95%
CI: 24.52-28.13) (Figure 4) in the healthy, mild,
and severe PE groups, respectively. As seen in
Table II, the mean maternal age in the healthy
and affected groups was 26.21 and 28.20 years,
respectively, which indicates the effect of age
on the disorder, considering the studied vari-
able (BMI); however, this relationship was not
significant. Also, the mean systolic and diastolic
blood pressure was 142.75, 99.26 and 101.59,
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70.76 mmHg in the affected and healthy groups,
respectively, which indicates a direct relationship
between hypertension and preeclampsia. These
results revealed that hypertension is somewhat
associated with an increase in BMI. Also, the
average week of pregnancy in the healthy and
affected mothers is 34.15 and 33.82 weeks,
respectively, which seems to indicate no specific
relationship between individuals with preeclamp-
sia and BMI with the average week of preg-
nancy.
According to the publication bias figure, Beggs
test showed that the effect of bias in these studies
was significant. (p = 0.584) (Figure 5).
Table II. The mean of variables in the studies
Variables Number of study 95% confidence interval
Healthy group 13 26.21 (24.04-28.38)Mean age of pregnant mothers
Affected group 2 28.20 (26.61-29.80)
Healthy mothers 5 101.59 (96.60-106.58)Mean systolic blood pressure
Affected mothers 5 142.75 (132.12-153.38)
Healthy mothers 7 70.76 (65.87-75.65)Mean diastolic blood pressure
Affected mothers 7 99.26 (91.74-106.79)
Healthy mothers 8 34.15 (37.16-31.15)Mean week of pregnancy
Affected mothers 8 33.82 (30.67-36.96)
Healthy mothers 2 159.14 (157.04-161.24)Mean maternal height (in cm)
Affected mothers 2 159.19 (157.90-160.47)
Healthy mothers 2 3094.39 (2837.84-3350.92)Mean maternal weight (gr)
Affected mothers 2 2508 (1903.35-3113.83)
Healthy mothers 11 25.13 (23.52-26.74)
Affected mothers (mild) 2 27.42 (24.49-30.34)Mean BMI
Affected mothers (severe) 11 26.33 (24.52-28.13)
Healthy mothers 8 34 (31-37)Mean pregnancy week
Affected mothers 8 33 (30-37)
Healthy mothers 5 101.50 (96.6-106.58)Mean blood pressure systolic
Affected mothers 5 147.75 (132.12-153.38)
Healthy mothers 7 56.24 (32.36-80.12)Mean blood pressure diastolic 8
Affected mothers 7 81.49 (64.03-98.95)
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Figure 2. BMI in healthy pregnant women, by year, prevalence rate, and 95% CI interval. Each line segment shows the CI length.
The diamond sign indicates the result of combining all studies at 95% CI.
Figure 3. The BMI value in pregnant women with mild PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI
length. The diamond sign indicates the result of combining all studies at 95% CI.
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Figure 4. The BMI value in pregnant with severe PE, by year, prevalence rate, and 95% CI. Each line segment shows the CI length.
The diamond sign indicates the result of combining all studies at 95% CI.
Figure 5. Beggs Funnel plot for publication bias.
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4. Discussion
In this study, the average age of the mothers
was 21.26 years in the healthy group and 20.28
years in the affected mothers. The average height
of mothers was 159.14 cm in the healthy group
and 159.19 cm in the affected group. Finally, the
mean value of BMI was 25.13% in the healthy group
and 26.33% in the (severely) affected group. The
highest BMI in the healthy pregnant women was
29.14% and the lowest one was 21.95%. Further-
more, the highest BMI in the pregnant women
with preeclampsia was 30.35% and the lowest
was 22.39%. Moreover, in this study, the general
prevalence of preeclampsia (severe) was 7% and
the general prevalence of preeclampsia (mild) was
obtained as 23%. The mean systolic hypertension
in the studied group was 142.75 mmHg, while that
of the healthy group was 101.59 mmHg, and the
mean diastolic hypertension was 99.26 mmHg in
the affected group and 70.76 mmHg in the healthy
mothers.
According to the results obtained earlier, it can
be concluded that the relationship between age
and the incidence of intended disorder considering
BMI was not significant. Further, there is no specific
relationship between those with preeclampsia and
BMI with the mean of gestational age.
Hypertension has a direct relationship with
preeclampsia. According to these results, it can be
concluded that hypertension is one of the factors
that increases BMI in pregnant women. Addition-
ally, high BMI has a relationship with preeclampsia
in pregnant women. This result is relatively consis-
tent with Brown’s study; in the Brown’s study, the
percentage of preeclampsia prevalence (4.5%) in
womenwith light weight is approximately half of the
women with normal weight (0.09) (31).
In a study by Vahid Roodsari et al. BMI was
reported to be 24 kg/m2 in the pre-pregnancy
control group, 26.124 kg/m2 in the gestational
hypertension group, 26.24 kg/m2 in the group
with mild preeclampsia and 26.24 kg/m2 in the
severe preeclampsia group. It has been reported
(32), according to the obtained results, that if
weight increases before pregnancy, weight loss will
prevent mortality during pregnancy. Jang et al. in
Seoul, Korea, compared two groups and showed
that the incidence of preeclampsia in women with
overweight women is higher than those of normal
weight (33). Derif et al. also stated that hyperten-
sion problems occurs more in overweight women
indicating its incidence 7% to 17% (34). Kramer, in a
researcher at theUniversity of NewYork, found that
as the BMI increases among themothers, the risk of
cesarean operation will increase significantly (35).
In the study by Ohkuchi et al. the incidence
of hypertension during pregnancy in women with
less weight, normal weight, weight more than
normal, and obese was 1.1%, 1.8%, 5.8%, and 19.6%,
respectively, which besides its consistency with the
results of this study, indicates that the incidence
of pre-pregnancy hypertension in obese women
significantly increases (36). Sibai also reported in
a study that high weight before pregnancy is an
important risk factor for pregnancy toxicity (37).
These results are relatively consistent with the con-
ducted study. In addition, in a study by Bondar in
the United States, it was shown that 56% of women
with gestational toxicity were suffering from either
overweight or obesity, and every 4-unit increase
in BMI was related to twice the risk of gestational
toxicity and an 8-unit increase in BMI was related
to three times the risk of gestational toxicity (38). In
another study by Belogolovkin et al. in the United
States, it was concluded that the probability of
a pregnancy-related hypertention in women with
a high BMI (26.1-29 kg/m2) was 6%, whereas in
women with a normal BMI (19.86-26 kg/m2) it was
3.2%, and the probability of pregnancy toxicity in
women with normal BMI is 1.9%, whilein women
with a high BMI, it was 2.8% (39).
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Cogswell and Yip, in the United States, showed
that women with high BMI have more deliveries
(40). In the conducted study alsowomenwith heavy
weight had more deliveries.
Naevy et al., found that the prenatal mortality
was higher in women with heavy weight than other
groups, and it is said that the reason behind it lies
in the increased multiple pregnancy and preterm
birth (41).
Women with high BMI have adverse effects of
pregnancy, delivery, and neonate, and even in
the pre-pregnancy period; women with abnormal
weight face with problems such as polycystic
ovary, infertility, and failure in infertility treatments
(41). Pregnant women with abnormal weight and
obesity are subject to the risk of diabetes mellitus
type 2, gestational diabetes, and preeclampsia
(42), thromboembolic diseases (43), dyspnea (44),
asthma (45), cholecystitis (46), back pain, pelvic
pain (47) and urinary incontinence (48).
4.1. Problems regarding data extrac-
tion
Among the problemswe encountered during the
data extraction in this article were the irrelevancy of
the article to the stated subject, the inaccessibility
of the full text of the article, and the incomplete
information given in the abstract part of the article.
The control of all discomfit factors was not possible,
and factors such as diet are effective factors that
have not been measured in studies.
5. Conclusion
This meta-analysis study, in which BMI was
evaluated, showed that the risk of preeclampsia
may increase with an increase in BMI. Therefore,
BMI can be considered as one of the ways to
diagnose the preeclampsia.
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